Background
==========

Renal cell carcinoma (RCC) has a potential to metastasize to almost any site. In descending order of frequency, the most common sites of metastasis are the lung, lymph nodes, liver, bone, adrenal glands, kidney, brain, heart, spleen, intestine, and skin \[[@B1]\]. It can involve any part of the bowel and accounts for 7.1% of all metastatic tumours to small intestine \[[@B2]\]. Duodenal metastasis from RCC is very uncommon and only few cases have been described in the English literature (table [1](#T1){ref-type="table"}) \[[@B3]-[@B18]\]. Also duodenal metastasis generally occurs when there is widespread nodal and visceral involvement and evidence of metastatic disease elsewhere in the body. Here we present the case report of a patient with duodenal and liver metastasis who presented with jaundice and right sided abdominal lump one year after nephrectomy. Duodenal biopsy performed revealed metastasis in the duodenum.

###### 

Previously reported examples of duodenal metastasis in patients with renal cell carcinoma

  **Author**               **Year**   **Age/Sex**   **Duration post-nephrectomy**   **Presenting symptoms**   **Other organs involved**   **Treatment**                   **Patient outcome**
  ------------------------ ---------- ------------- ------------------------------- ------------------------- --------------------------- ------------------------------- ---------------------
  Lawson et al \[3\]       1966       69/F          0 years                         Bleeding anemia           \-                          Pancreatico-duodenectomy        Alive (8 months FU)
  Tolia et al \[4\]        1975       -/M           16 years                        \-                        \-                          \-                              5 months
  Heymann et al \[5\]      1978       64/M          8 years                         Bleeding                  Colon                       Complex procedure               3 weeks
  McNichols et al \[6\]    1981       52/M          10 years                        Malabsorption             \-                          Diagnostic only                 \-
  Lynch et al \[7\]        1987       16/M          1 year                          Bleeding                  \-                          Embolization                    Alive (6 months FU)
                                      61/M          6 years                         Jaundice                  \-                          Embolization                    6 months
                                      67/M          2 years                         Bleeding                  Lungs                       \-                              Lost to FU
  Robertson et \[8\]       1990       70/M          13 years                        Bleeding                  Pancreas                    Whipple procedure               \-
  Gastaca et al \[9\]      1996       \-            8 years                         \-                        \-                          Duodenectomy                    \-
  Toh et al \[10\]         1996       59/F          10 years                        Obstruction anemia        \-                          Metastatectomy                  Alive (6 months FU)
  Ohmura et al \[11\]      2000       62/M          5 years                         Obstruction               \-                          Embolization- local resection   \-
  Hashimoto et al \[12\]   2001       57/M          11 years                        Bleeding                  Pancreas                    PPPD                            \-
  Nabi et al \[13\]        2001       40/M          4 years                         Obstruction               \-                          Gastrojujenostomy               7 days
  Sawh et al \[14\]        2002       53/M          6 years                         Bleeding                  Brain Anal canal            Duodenectomy                    Alive (4 years FU)
  Loualidi et al \[15\]    2004       76/M          5 years                         Anemia                    \-                          Radiotherapy                    Alive
  Chang et al \[16\]       2004       63/F          9 years                         Bleeding                  \-                          Metastatectomy                  \-
  George et al \[16\]      2004       65/M          2 years                         Obstruction               Omentum ileum               Intestinal Resection            9 months
  Arroyo \[17\]            2005       \-            \-                              \-                        \-                          \-                              \-
  Bhatia et al (current)   2006       50/M          1 year                          Jaundice                  Liver                       Diagnostic only                 Lost to FU

PPPD = Pylorus preserving pancreatico-duodenectomy, FU = Follow up

Report of a case
================

The patient was a 55 years old male who came to gastroenterology out patient department with complaints of jaundice and an abdominal mass. He had a history of RCC in the left kidney and had undergone left radical nephrectomy one year ago in our institute. The tumour was present in the lower pole and measured 7 × 5 × 6 cm. Microscopically, it was a conventional clear cell carcinoma (Furhman grade III) involving the renal sinus with tumour emboli in the renal vein. The adrenal gland and ureter were free. This time the patient had jaundice and an abdominal lump. An upper gastrointestinal endoscopy (UGIE) followed by duodenal biopsy was performed. Endoscopy showed a 4 × 4 cm submucosal mass lesion (Fig. [1](#F1){ref-type="fig"}) in the second part of duodenum. A biopsy was taken from the mass and sent for histopathology.

![Endoscopic view of submucosal mass lesion in second part of duodenum, with normal glistening mucosa.](1746-1596-1-29-1){#F1}

The biopsy consisted of three fragments which revealed duodenal mucosa with normal villi, however many of the vascular channels in the lamina propria showed tumour emboli. The tumour cells were mildly pleomorphic, had abundant pink cytoplasm and low nuclear:cytoplasmic ratio (Fig. [2](#F2){ref-type="fig"}). These were positive for cytokeratin (CK), vimentin (Vim) and epithelial membrane antigen immunostaining and negative for chromogranin (Fig. [3](#F3){ref-type="fig"}). The surrounding lamina propria, villi and crypts were normal. Considering these features, a diagnosis of metastatic renal cell carcinoma was offered on the biopsy. This was followed by abdominal Ultrasonography (USG), CT scan, liver function tests and other investigations to know the extent of illness. Liver enzymes were raised significantly with serum alkaline phosphatase levels of \> 1000 IU/L. Both USG and CT scan showed multiple tumour deposits in the liver. Other visceral organs and peritoneum were normal. Radiotherapy as a part of palliative treatment was planned but could not be performed as the patient was lost to follow up.
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Discussion
==========

Small bowel involvement by metastatic tumors is rare and has been reported in only 2% of autopsy cases \[[@B2]\]. Common metastatic malignancies known to involve the small bowel are melanomas, lung cancer, carcinoma of the cervix, RCC, thyroid carcinoma, hepatoma and merkel cell carcinoma. Males are more commonly affected (male: female = 1.5:1) and the incidence of metastasis increases with age \[[@B17]\]. Metastatic lesions of the duodenum are most frequently located in the periampullary region or the duodenal bulb \[[@B17]\]. On endoscopy the lesion can be seen as a submucosal mass with ulceration of the tip, multiple nodules of varying sizes or raised plaques \[[@B19]\]. In the present case the metastatic lesion was seen as a 4 × 4 cm submucosal mass in the 2^nd^part of duodenum. The patients commonly present with gastrointestinal bleeding or intestinal obstruction \[[@B10],[@B17]\], however our patient presented with jaundice and abdominal lump. On investigation he was found to have liver metastasis also.

The majority of patients are found to have metastasis within a year after nephrectomy though it can be seen even after several years \[[@B16]\]. The routes of spread can be (i) peritoneal dissemination, (ii) direct spread from an intra-abdominal malignancy, (iii) hematogenous and (iv) lymphatic spread \[[@B17]\]. The last two mechanisms can be responsible for metastases in the case reported.

Treatment options in a case of RCC metastasis depend upon the extent and location of the lesion. In the majority of reported cases of duodenal metastasis, metastatectomy was done. However for disseminated malignancy like in our case treatment is in the form of palliative (non-curative) surgery, radiotherapy, chemotherapy (Sunitinib) or immune stimulating agents (Interleukin-2). However even after treatment the patients with metastatic disease have poor survival. The average survival is about 4 months and only 10% of these survive for one year \[[@B20]\].

The report therefore highlights the importance of investigating patients of RCC presenting with any gastro-intestinal tract manifestations for metastasis. A complete evaluation, especially endoscopic examination and biopsy, should be carried out in such patients. Awareness of this entity and a high index of suspicion on the part of the treating physician and pathologist would help in proper diagnosis and treatment.
